MedPath
NMPA Approval

Sacituzumab Tirumotecan for Injection

国药准字S20240052

November 22, 2024

Drug Information

注射用芦康沙妥珠单抗

佳泰莱

注射剂

200mg/瓶

生物制品

November 22, 2024

Company Information

Applicant Company

四川省成都市温江区成都海峡两岸科技产业开发园区新华大道666号

Manufacturing Company

成都市温江区成都海峡两岸科技产业开发园区新华大道666号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

注射用芦康沙妥珠单抗 - NMPA 批准文号 | MedPath